PHMPharma Mar, S.A.
99.25EUR-0.75%Mkt Cap: 1.72B EURP/E: 21.53Last update: 2026-06-01

Pharma Mar, S.A., a biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, res…

Indicators:|

Key Statistics

Company
Market Cap1.72B EUR
Enterprise Value1.62B EUR
Revenue (TTM)225.43M EUR
Gross Profit209.13M EUR
Net Income (TTM)74.99M EUR
Revenue/Share12.98 EUR
Last Price99.25 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees505
CountryES
SectorHealthcare
IndustryBiotechnology
ISINES0169501022
Valuation
P/E (Trailing)21.53
P/E (Forward)13.55
PEG0.31
EV/EBITDA22.99
EV/Revenue7.17
P/S7.68
P/B6.95
EPS (TTM)4.62
EPS (Forward)7.38
52W Range
70.1083% of range105.20
52W High105.20 EUR
52W Low70.10 EUR
Profitability
Gross Margin94.46%
Oper. Margin1.45%
EBITDA Margin31.17%
Profit Margin33.87%
ROE29.78%
ROA18.98%
Growth
Revenue Growth10.40%
Earnings Growth
Cash Flow & Leverage
Operating CF53.13M EUR
CapEx (TTM)9.38M EUR
FCF Margin15.56%
FCF Yield2.04%
Net Debt-120.32M EUR
Net Debt/EBITDA-1.71
Balance Sheet
Debt/Equity0.20
Current Ratio3.06
Quick Ratio2.33
Book Value/Sh14.38 EUR
Cash/Share9.669 EUR
Dividends
Fwd Div Rate0.8000 EUR
Trail. Div Rate0.0000 EUR
Div. Yield0.79%
5Y Avg Yield
Payout Ratio17.34%
Ex-Div DateJun 25, 2025
Pay Date
Splits
Last Split1:12
Split DateJul 22, 2020
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)108.89 EUR
Target Range75.00 EUR125.00 EUR
# Analysts9
Ownership
Shares Out.17.31M
Float13.43M
Insiders29.74%
Institutions8.32%
Technical
SMA 5094.64 (+4.9%)
SMA 20083.52 (+18.8%)
Beta0.37
S&P 52W Chg27.94%
Avg Vol (30d)65.07K
Avg Vol (10d)44.44K
Technical Indicators
RSI (14)56.5
MACD1.5619
MACD Signal1.6551
MACD Hist.-0.0931
BB Upper104.63 EUR
BB Middle99.29 EUR
BB Lower93.94 EUR
BB Width10.77%
ATR (14)3.255 EUR
Vol Ratio (20d)1.52x